148 related articles for article (PubMed ID: 20502405)
1. Comparison of selected methods for fracture risk assessment in postmenopausal women: analysis of the Łódź population in the EPOLOS study.
Skowrońska-Jóźwiak E; Wójcicka A; Lorenc RS; Lewiński A
Pol Arch Med Wewn; 2010 May; 120(5):197-202. PubMed ID: 20502405
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of densitometry and fracture risk assessment tool FRAX in making therapeutic decisions in osteoporosis--a study on female patients of university of medical sciences endocrinology outpatient clinic].
Ignaszak-Szczepaniak M; Dytfeld J; Michalak M; Gowin E; Horst-Sikorska W
Ginekol Pol; 2009 Jun; 80(6):424-31. PubMed ID: 19642598
[TBL] [Abstract][Full Text] [Related]
3. The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland.
Badurski JE; Kanis JA; Johansson H; Dobreńko A; Nowak NA; Daniluk S; Jezienicka E
Pol Arch Med Wewn; 2011 May; 121(5):148-55. PubMed ID: 21610662
[TBL] [Abstract][Full Text] [Related]
4. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
[TBL] [Abstract][Full Text] [Related]
5. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
Watts NB
J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
[TBL] [Abstract][Full Text] [Related]
6. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
[TBL] [Abstract][Full Text] [Related]
8. An optimal intervention threshold of FRAX in postmenopausal Thai women.
Sribenjalak D; Charoensri S; Pongchaiyakul C
Arch Osteoporos; 2022 Jan; 17(1):21. PubMed ID: 35072805
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of FRAX Score without bone mineral density determination and the criteria proposed by the Argentine Osteoporosis Society for the use of antiresorptive therapy in postmenopausal women].
Camporro F; Redondo L; Bulacio E; Gutiérrez Magaldi I; Chamale E; Sáenz F
Medicina (B Aires); 2015; 75(3):155-8. PubMed ID: 26117605
[TBL] [Abstract][Full Text] [Related]
10. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
[TBL] [Abstract][Full Text] [Related]
11. Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
Baró F; Cano A; Sánchez Borrego R; Ferrer J; González Rodríguez SP; Neyro JL; Rodriguez Bueno E; Sancho C; Inaraja V; Fernández C; Corral C;
Menopause; 2012 Nov; 19(11):1193-9. PubMed ID: 22948137
[TBL] [Abstract][Full Text] [Related]
12. Application of FRAX model to Sri Lankan postmenopausal women.
Lekamwasam S
J Clin Densitom; 2010; 13(1):51-55. PubMed ID: 19926321
[TBL] [Abstract][Full Text] [Related]
13. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
Kanis JA; Johansson H; Oden A; McCloskey EV
Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
[TBL] [Abstract][Full Text] [Related]
14. Fracture risk prediction in postmenopausal women from GO Study: the comparison between FRAX, Garvan, and POL-RISK algorithms.
Pluskiewicz W; Werner A; Bach M; Adamczyk P; Drozdzowska B
Arch Osteoporos; 2024 May; 19(1):39. PubMed ID: 38755326
[TBL] [Abstract][Full Text] [Related]
15. Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka.
Lekamwasam S; Chandran M; Subasinghe S
Arch Osteoporos; 2019 Mar; 14(1):33. PubMed ID: 30850909
[TBL] [Abstract][Full Text] [Related]
16. A discussion of the intervention thresholds in osteoporosis treatment in Poland.
Marcinkowska M; Ignaszak-Szczepaniak M; Wawrzyniak A; Dytfeld J; Marcinkowska WH; Ignaszak-Szczepaniak M; Wawrzyniak A; Dytfeld J; Horst-Sikorska W
Endokrynol Pol; 2011; 62(1):30-6. PubMed ID: 21365576
[TBL] [Abstract][Full Text] [Related]
17. Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures.
Ahmed LA; Shigdel R; Joakimsen RM; Eldevik OP; Eriksen EF; Ghasem-Zadeh A; Bala Y; Zebaze R; Seeman E; Bjørnerem Å
Osteoporos Int; 2015 Aug; 26(8):2137-46. PubMed ID: 25876879
[TBL] [Abstract][Full Text] [Related]
18. Height loss in postmenopausal women-do we need more for fracture risk assessment? Results from the GO Study.
Pluskiewicz W; Adamczyk P; Drozdzowska B
Osteoporos Int; 2021 Oct; 32(10):2043-2049. PubMed ID: 33818635
[TBL] [Abstract][Full Text] [Related]
19. [FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].
Azagra R; Roca G; Martín-Sánchez JC; Casado E; Encabo G; Zwart M; Aguyé A; Díez-Pérez A;
Med Clin (Barc); 2015 Jan; 144(1):1-8. PubMed ID: 24461732
[TBL] [Abstract][Full Text] [Related]
20. Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold.
Wang Y; Yu S; Hsu C; Tsai C; Cheng T
Osteoporos Int; 2020 Mar; 31(3):475-483. PubMed ID: 31696272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
